IVA healthcare gave Diwali wishings to their IVA family members

IVA healthcare giving credits of their success to their dedicated team. IVA family wishing all of their associates and channel partners a very happy and prosperous Deepawali. IVA CEO “Manish Bansal” extended Diwali greetings to their members and hoping this Diwali will bring joy and prosperity to the life of their IVA members.

IVA healthcare working to bring the betterment to the life of people through high-quality healthcare products. Affordability with good quality of medicines to help people to get rid of their suffering, pain & illness from the world, is the aim of the IVA. IVA is a Greek word which means “God’s Gift” and as per its name, IVa healthcare wants to gift good health through their products.

IVA healthcare make use of the features of technical advancement to help human endeavor to excel. IVA made their reputation as a Wholesaler as well as a trader in various healthcare products.

With an annual turnover of up to 5 crores, IVA achieved a numero uno position in the industry. To send products all over the country, IVA has a capacious warehouse with a large area and connected to national highways.

This year 2018, the company achieved the healthy and best performance with the contribution of their team efforts. The company is actively dedicated to prioritizing new medical innovation with enhanced capabilities and improved efficiency, helping us to realize their marketing strategy, and driving their next phase of growth.

The company proved themselves for true quality commitments and that is one of the reasons to be successful.

 

Related Posts

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre